D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRS
3576
DELISTED
Verso Corporation
VRS
| $191K | ﹤0.01% |
16,953
-18,143
| -52% | -$283K |
|
|
BRY
3577
DELISTED
Berry Corp
BRY
| $190K | ﹤0.01% |
78,900
+15,671
| +25% | +$96.2K |
|
3578
PUT
Century Aluminum
CENX
$4.57B
| $190K | ﹤0.01% |
+52,500
| New | +$294K |
|
|
WTRE
3579
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $190K | ﹤0.01% |
12,965
-3,917
| -23% | -$86K |
|
|
BMY.RT
3580
CALL
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $190K | ﹤0.01% |
50,000
-104,200
| -68% | -$343K |
|
3581
PUT
Ethan Allen Interiors
ETD
$581M
| $189K | ﹤0.01% |
+18,500
| New | +$270K |
|
3582
Kosmos Energy
KOS
$1.56B
| $189K | ﹤0.01% |
211,413
-1,492,516
| -88% | -$5.93M |
|
3583
PUT
Antero Midstream
AM
$10.8B
| $188K | ﹤0.01% |
89,600
| – | – |
|
|
FNHC
3584
DELISTED
FedNat Holding Company Common Stock
FNHC
| $188K | ﹤0.01% |
+16,362
| New | +$229K |
|
3585
Wabash National
WNC
$543M
| $187K | ﹤0.01% |
25,900
-256,722
| -91% | -$2.88M |
|
3586
CALL
Matador Resources
MTDR
$6.31B
| $186K | ﹤0.01% |
+75,000
| New | +$824K |
|
|
AWF
3587
AllianceBernstein Global High Income Fund
AWF
$867M
| $185K | ﹤0.01% |
+20,000
| New | +$228K |
|
3588
PUT
B&G Foods
BGS
$285M
| $185K | ﹤0.01% |
10,200
-5,800
| -36% | -$90.8K |
|
|
DHC
3589
Diversified Healthcare Trust
DHC
$2.26B
| $182K | ﹤0.01% |
50,100
-23,447
| -32% | -$154K |
|
3590
CALL
Kohl's
KSS
$2.03B
| $182K | ﹤0.01% |
12,500
-118,800
| -90% | -$4.45M |
|
|
RVNC
3591
DELISTED
Revance Therapeutics, Inc.
RVNC
| $182K | ﹤0.01% |
+12,300
| New | +$254K |
|
|
DCH
3592
CALL
Dauch Corp
DCH
$1.3B
| $181K | ﹤0.01% |
50,000
-4,200
| -8% | -$31.2K |
|
|
HTT
3593
PUT
High Templar Tech Ltd
HTT
$377M
| $180K | ﹤0.01% |
+100,000
| New | +$281K |
|
|
PDCE
3594
DELISTED
PDC Energy, Inc.
PDCE
| $178K | ﹤0.01% |
28,716
+11,405
| +66% | +$205K |
|
3595
NN Inc
NNBR
$272M
| $177K | ﹤0.01% |
102,259
+62,356
| +156% | +$446K |
|
3596
PUT
Olin
OLN
$2.64B
| $177K | ﹤0.01% |
15,200
-218,500
| -93% | -$3.31M |
|
3597
Construction Partners
ROAD
$5.84B
| $177K | ﹤0.01% |
10,461
-5,277
| -34% | -$87.7K |
|
|
BBBY
3598
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
| $176K | ﹤0.01% |
41,900
-18,100
| -30% | -$211K |
|
|
AIMT
3599
DELISTED
Aimmune Therapeutics
AIMT
| $176K | ﹤0.01% |
12,200
-19,115
| -61% | -$489K |
|
|
EPZM
3600
DELISTED
Epizyme, Inc
EPZM
| $173K | ﹤0.01% |
11,124
-177,300
| -94% | -$3.81M |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.